Inflammatory Cutaneous Lesions in Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab: An ECCO CONFER Multicentre Case Series
Frank M. Phillips(Rush University Medical Center), Uri Kopylov(Sheba Medical Center), Francesca Vincenzi(University of Parma), Bram Verstockt(Universitair Ziekenhuis Leuven), Shaji Sebastian(University of Hull), Cristina Flores(Hospital de Clínicas de Porto Alegre), Eoin Slattery(University Hospital Galway), E. Capoferro(University of Parma), Oliver Bachmann(Medizinische Hochschule Hannover), Davide Giuseppe Ribaldone(University of Turin), Κωνσταντίνος Κατσάνος(University of Ioannina), Walter Fries(University of Messina), Stephan R. Vavricka(Triemli Hospital), N de Suray(Grand Charleroi Hospital)
Cited by 46
Related Papers
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
Environmental triggers in IBD: a review of progress and evidence
|Nature Reviews Gastroenterology & Hepatology|2017|931